Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats

White matter damage (WMD) and bronchopulmonary dysplasia (BPD) are the two main complications occurring in very preterm infants. Inhaled nitric oxide (iNO) has been proposed to promote alveolarization in the developing lung, and we have reported that iNO promotes myelination and induces neuroprotect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2014-02, Vol.252, p.114-123
Hauptverfasser: Pham, Hoa, Vottier, Gaelle, Pansiot, Julien, Duong-Quy, Sy, Bollen, Bieke, Dalous, Jérémie, Gallego, Jorge, Mercier, Jean-Christophe, Dinh-Xuan, Anh Tuan, Bonnin, Philippe, Charriaut-Marlangue, Christiane, Baud, Olivier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue
container_start_page 114
container_title Experimental neurology
container_volume 252
creator Pham, Hoa
Vottier, Gaelle
Pansiot, Julien
Duong-Quy, Sy
Bollen, Bieke
Dalous, Jérémie
Gallego, Jorge
Mercier, Jean-Christophe
Dinh-Xuan, Anh Tuan
Bonnin, Philippe
Charriaut-Marlangue, Christiane
Baud, Olivier
description White matter damage (WMD) and bronchopulmonary dysplasia (BPD) are the two main complications occurring in very preterm infants. Inhaled nitric oxide (iNO) has been proposed to promote alveolarization in the developing lung, and we have reported that iNO promotes myelination and induces neuroprotection in neonatal rats with excitotoxic brain damage. Our hypothesis is that, in addition to its pulmonary effects, iNO may be neuroprotective in rat pups exposed to hyperoxia. To test this hypothesis, we exposed rat pups to hyperoxia, and we assessed the impact of iNO on WMD and BPD. Rat pups were exposed to either hyperoxia (80% FiO2) or to normoxia for 8days. Both groups received iNO (5ppm) or air. We assessed the neurological and pulmonary effects of iNO in hyperoxia-injured rat pups using histological, molecular and behavioral approaches. iNO significantly attenuated the severity of hyperoxia-induced WMD induced in neonatal rats. Specifically, iNO decreased white matter inflammation, cell death, and enhanced the density of proliferating oligodendrocytes and oligodendroglial maturation. Furthermore, iNO triggered an early upregulation of P27kip1 and brain-derived growth factor (BDNF). Whereas hyperoxia disrupted early associative abilities, iNO treatment maintained learning scores to a level similar to that of control pups. In contrast to its marked neuroprotective effects, iNO induced only small and transient improvements of BPD. These findings suggest that iNO exposure at low doses is specifically neuroprotective in an animal model combining injuries of the developing lung and brain that mimicked BPD and WMD in preterm infants. •Postnatal hyperoxia induces injury on both developing brain and developing lung in neonatal rat.•Inhaled NO exposure attenuates white matter damage with significant behavioral impact.•Neuroprotective effects of inhaled NO appear unrelated to improvements in the histological markers of lung injury.
doi_str_mv 10.1016/j.expneurol.2013.11.025
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516756914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488613003580</els_id><sourcerecordid>1516756914</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-f9bc94a8c0ecf18f11b6ad37e16554003a65ea347aacedb57ad48bb35358dfd03</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhq0K1C6FvwC5IPWSMBPb-ThWFS1FFb3A2Zo4E9arfGEnpf339WqXcuxpDvO88_EI8QkhQ8Diyy7jx3nk1U99lgPKDDGDXJ-IDUINaa4kvBEbAFSpqqriTLwLYQcAtcrLU3EW-3kOWm7E99txSz23yY_7ZPb8wOMSku3TzH56dJS6sV1t7P7duoWTgZaFfdLSQL85cWMy8jTSQn3iaQnvxduO-sAfjvVc_Lr--vPqW3p3f3N7dXmXWiXVknZ1Y2tFlQW2HVYdYlNQK0vGQmsFIKnQTFKVRHFzo0tqVdU0UktdtV0L8lxcHObOfvqzcljM4ILlvqd4zhoMaixKXdSoXkdVjVBIUDqi5QG1fgrBc2dm7wbyTwbB7J2bnXlxbvbODaKJzmPy43HJ2gzcvuT-SY7A5yNAwVLfeRqtC_-5Ciso8_1jlweOo70Hx94E63iMFpxnu5h2cq8e8wzZmqQ3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1491063045</pqid></control><display><type>article</type><title>Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pham, Hoa ; Vottier, Gaelle ; Pansiot, Julien ; Duong-Quy, Sy ; Bollen, Bieke ; Dalous, Jérémie ; Gallego, Jorge ; Mercier, Jean-Christophe ; Dinh-Xuan, Anh Tuan ; Bonnin, Philippe ; Charriaut-Marlangue, Christiane ; Baud, Olivier</creator><creatorcontrib>Pham, Hoa ; Vottier, Gaelle ; Pansiot, Julien ; Duong-Quy, Sy ; Bollen, Bieke ; Dalous, Jérémie ; Gallego, Jorge ; Mercier, Jean-Christophe ; Dinh-Xuan, Anh Tuan ; Bonnin, Philippe ; Charriaut-Marlangue, Christiane ; Baud, Olivier</creatorcontrib><description>White matter damage (WMD) and bronchopulmonary dysplasia (BPD) are the two main complications occurring in very preterm infants. Inhaled nitric oxide (iNO) has been proposed to promote alveolarization in the developing lung, and we have reported that iNO promotes myelination and induces neuroprotection in neonatal rats with excitotoxic brain damage. Our hypothesis is that, in addition to its pulmonary effects, iNO may be neuroprotective in rat pups exposed to hyperoxia. To test this hypothesis, we exposed rat pups to hyperoxia, and we assessed the impact of iNO on WMD and BPD. Rat pups were exposed to either hyperoxia (80% FiO2) or to normoxia for 8days. Both groups received iNO (5ppm) or air. We assessed the neurological and pulmonary effects of iNO in hyperoxia-injured rat pups using histological, molecular and behavioral approaches. iNO significantly attenuated the severity of hyperoxia-induced WMD induced in neonatal rats. Specifically, iNO decreased white matter inflammation, cell death, and enhanced the density of proliferating oligodendrocytes and oligodendroglial maturation. Furthermore, iNO triggered an early upregulation of P27kip1 and brain-derived growth factor (BDNF). Whereas hyperoxia disrupted early associative abilities, iNO treatment maintained learning scores to a level similar to that of control pups. In contrast to its marked neuroprotective effects, iNO induced only small and transient improvements of BPD. These findings suggest that iNO exposure at low doses is specifically neuroprotective in an animal model combining injuries of the developing lung and brain that mimicked BPD and WMD in preterm infants. •Postnatal hyperoxia induces injury on both developing brain and developing lung in neonatal rat.•Inhaled NO exposure attenuates white matter damage with significant behavioral impact.•Neuroprotective effects of inhaled NO appear unrelated to improvements in the histological markers of lung injury.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2013.11.025</identifier><identifier>PMID: 24322053</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Administration, Inhalation ; Age Factors ; Animals ; Animals, Newborn ; Biological and medical sciences ; Blood Gas Analysis ; Brain-Derived Neurotrophic Factor - metabolism ; Cell Death ; Cyclin-Dependent Kinase Inhibitor p27 - metabolism ; Developing brain ; Disease Models, Animal ; Female ; Hyperoxia ; Hypoxia - complications ; Leukoencephalopathies - etiology ; Leukoencephalopathies - prevention &amp; control ; Lung - drug effects ; Lung - physiopathology ; Male ; Medical sciences ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology ; Neuroprotection ; Neuroprotective Agents - administration &amp; dosage ; Nitric oxide ; Nitric Oxide - administration &amp; dosage ; Pregnancy ; Rats ; Rats, Sprague-Dawley ; White matter damage</subject><ispartof>Experimental neurology, 2014-02, Vol.252, p.114-123</ispartof><rights>2013 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-f9bc94a8c0ecf18f11b6ad37e16554003a65ea347aacedb57ad48bb35358dfd03</citedby><cites>FETCH-LOGICAL-c434t-f9bc94a8c0ecf18f11b6ad37e16554003a65ea347aacedb57ad48bb35358dfd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014488613003580$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28180720$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24322053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pham, Hoa</creatorcontrib><creatorcontrib>Vottier, Gaelle</creatorcontrib><creatorcontrib>Pansiot, Julien</creatorcontrib><creatorcontrib>Duong-Quy, Sy</creatorcontrib><creatorcontrib>Bollen, Bieke</creatorcontrib><creatorcontrib>Dalous, Jérémie</creatorcontrib><creatorcontrib>Gallego, Jorge</creatorcontrib><creatorcontrib>Mercier, Jean-Christophe</creatorcontrib><creatorcontrib>Dinh-Xuan, Anh Tuan</creatorcontrib><creatorcontrib>Bonnin, Philippe</creatorcontrib><creatorcontrib>Charriaut-Marlangue, Christiane</creatorcontrib><creatorcontrib>Baud, Olivier</creatorcontrib><title>Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>White matter damage (WMD) and bronchopulmonary dysplasia (BPD) are the two main complications occurring in very preterm infants. Inhaled nitric oxide (iNO) has been proposed to promote alveolarization in the developing lung, and we have reported that iNO promotes myelination and induces neuroprotection in neonatal rats with excitotoxic brain damage. Our hypothesis is that, in addition to its pulmonary effects, iNO may be neuroprotective in rat pups exposed to hyperoxia. To test this hypothesis, we exposed rat pups to hyperoxia, and we assessed the impact of iNO on WMD and BPD. Rat pups were exposed to either hyperoxia (80% FiO2) or to normoxia for 8days. Both groups received iNO (5ppm) or air. We assessed the neurological and pulmonary effects of iNO in hyperoxia-injured rat pups using histological, molecular and behavioral approaches. iNO significantly attenuated the severity of hyperoxia-induced WMD induced in neonatal rats. Specifically, iNO decreased white matter inflammation, cell death, and enhanced the density of proliferating oligodendrocytes and oligodendroglial maturation. Furthermore, iNO triggered an early upregulation of P27kip1 and brain-derived growth factor (BDNF). Whereas hyperoxia disrupted early associative abilities, iNO treatment maintained learning scores to a level similar to that of control pups. In contrast to its marked neuroprotective effects, iNO induced only small and transient improvements of BPD. These findings suggest that iNO exposure at low doses is specifically neuroprotective in an animal model combining injuries of the developing lung and brain that mimicked BPD and WMD in preterm infants. •Postnatal hyperoxia induces injury on both developing brain and developing lung in neonatal rat.•Inhaled NO exposure attenuates white matter damage with significant behavioral impact.•Neuroprotective effects of inhaled NO appear unrelated to improvements in the histological markers of lung injury.</description><subject>Administration, Inhalation</subject><subject>Age Factors</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Biological and medical sciences</subject><subject>Blood Gas Analysis</subject><subject>Brain-Derived Neurotrophic Factor - metabolism</subject><subject>Cell Death</subject><subject>Cyclin-Dependent Kinase Inhibitor p27 - metabolism</subject><subject>Developing brain</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Hyperoxia</subject><subject>Hypoxia - complications</subject><subject>Leukoencephalopathies - etiology</subject><subject>Leukoencephalopathies - prevention &amp; control</subject><subject>Lung - drug effects</subject><subject>Lung - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><subject>Neuroprotection</subject><subject>Neuroprotective Agents - administration &amp; dosage</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - administration &amp; dosage</subject><subject>Pregnancy</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>White matter damage</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhq0K1C6FvwC5IPWSMBPb-ThWFS1FFb3A2Zo4E9arfGEnpf339WqXcuxpDvO88_EI8QkhQ8Diyy7jx3nk1U99lgPKDDGDXJ-IDUINaa4kvBEbAFSpqqriTLwLYQcAtcrLU3EW-3kOWm7E99txSz23yY_7ZPb8wOMSku3TzH56dJS6sV1t7P7duoWTgZaFfdLSQL85cWMy8jTSQn3iaQnvxduO-sAfjvVc_Lr--vPqW3p3f3N7dXmXWiXVknZ1Y2tFlQW2HVYdYlNQK0vGQmsFIKnQTFKVRHFzo0tqVdU0UktdtV0L8lxcHObOfvqzcljM4ILlvqd4zhoMaixKXdSoXkdVjVBIUDqi5QG1fgrBc2dm7wbyTwbB7J2bnXlxbvbODaKJzmPy43HJ2gzcvuT-SY7A5yNAwVLfeRqtC_-5Ciso8_1jlweOo70Hx94E63iMFpxnu5h2cq8e8wzZmqQ3</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Pham, Hoa</creator><creator>Vottier, Gaelle</creator><creator>Pansiot, Julien</creator><creator>Duong-Quy, Sy</creator><creator>Bollen, Bieke</creator><creator>Dalous, Jérémie</creator><creator>Gallego, Jorge</creator><creator>Mercier, Jean-Christophe</creator><creator>Dinh-Xuan, Anh Tuan</creator><creator>Bonnin, Philippe</creator><creator>Charriaut-Marlangue, Christiane</creator><creator>Baud, Olivier</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20140201</creationdate><title>Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats</title><author>Pham, Hoa ; Vottier, Gaelle ; Pansiot, Julien ; Duong-Quy, Sy ; Bollen, Bieke ; Dalous, Jérémie ; Gallego, Jorge ; Mercier, Jean-Christophe ; Dinh-Xuan, Anh Tuan ; Bonnin, Philippe ; Charriaut-Marlangue, Christiane ; Baud, Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-f9bc94a8c0ecf18f11b6ad37e16554003a65ea347aacedb57ad48bb35358dfd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Inhalation</topic><topic>Age Factors</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Biological and medical sciences</topic><topic>Blood Gas Analysis</topic><topic>Brain-Derived Neurotrophic Factor - metabolism</topic><topic>Cell Death</topic><topic>Cyclin-Dependent Kinase Inhibitor p27 - metabolism</topic><topic>Developing brain</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Hyperoxia</topic><topic>Hypoxia - complications</topic><topic>Leukoencephalopathies - etiology</topic><topic>Leukoencephalopathies - prevention &amp; control</topic><topic>Lung - drug effects</topic><topic>Lung - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><topic>Neuroprotection</topic><topic>Neuroprotective Agents - administration &amp; dosage</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - administration &amp; dosage</topic><topic>Pregnancy</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>White matter damage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pham, Hoa</creatorcontrib><creatorcontrib>Vottier, Gaelle</creatorcontrib><creatorcontrib>Pansiot, Julien</creatorcontrib><creatorcontrib>Duong-Quy, Sy</creatorcontrib><creatorcontrib>Bollen, Bieke</creatorcontrib><creatorcontrib>Dalous, Jérémie</creatorcontrib><creatorcontrib>Gallego, Jorge</creatorcontrib><creatorcontrib>Mercier, Jean-Christophe</creatorcontrib><creatorcontrib>Dinh-Xuan, Anh Tuan</creatorcontrib><creatorcontrib>Bonnin, Philippe</creatorcontrib><creatorcontrib>Charriaut-Marlangue, Christiane</creatorcontrib><creatorcontrib>Baud, Olivier</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pham, Hoa</au><au>Vottier, Gaelle</au><au>Pansiot, Julien</au><au>Duong-Quy, Sy</au><au>Bollen, Bieke</au><au>Dalous, Jérémie</au><au>Gallego, Jorge</au><au>Mercier, Jean-Christophe</au><au>Dinh-Xuan, Anh Tuan</au><au>Bonnin, Philippe</au><au>Charriaut-Marlangue, Christiane</au><au>Baud, Olivier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>252</volume><spage>114</spage><epage>123</epage><pages>114-123</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>White matter damage (WMD) and bronchopulmonary dysplasia (BPD) are the two main complications occurring in very preterm infants. Inhaled nitric oxide (iNO) has been proposed to promote alveolarization in the developing lung, and we have reported that iNO promotes myelination and induces neuroprotection in neonatal rats with excitotoxic brain damage. Our hypothesis is that, in addition to its pulmonary effects, iNO may be neuroprotective in rat pups exposed to hyperoxia. To test this hypothesis, we exposed rat pups to hyperoxia, and we assessed the impact of iNO on WMD and BPD. Rat pups were exposed to either hyperoxia (80% FiO2) or to normoxia for 8days. Both groups received iNO (5ppm) or air. We assessed the neurological and pulmonary effects of iNO in hyperoxia-injured rat pups using histological, molecular and behavioral approaches. iNO significantly attenuated the severity of hyperoxia-induced WMD induced in neonatal rats. Specifically, iNO decreased white matter inflammation, cell death, and enhanced the density of proliferating oligodendrocytes and oligodendroglial maturation. Furthermore, iNO triggered an early upregulation of P27kip1 and brain-derived growth factor (BDNF). Whereas hyperoxia disrupted early associative abilities, iNO treatment maintained learning scores to a level similar to that of control pups. In contrast to its marked neuroprotective effects, iNO induced only small and transient improvements of BPD. These findings suggest that iNO exposure at low doses is specifically neuroprotective in an animal model combining injuries of the developing lung and brain that mimicked BPD and WMD in preterm infants. •Postnatal hyperoxia induces injury on both developing brain and developing lung in neonatal rat.•Inhaled NO exposure attenuates white matter damage with significant behavioral impact.•Neuroprotective effects of inhaled NO appear unrelated to improvements in the histological markers of lung injury.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>24322053</pmid><doi>10.1016/j.expneurol.2013.11.025</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2014-02, Vol.252, p.114-123
issn 0014-4886
1090-2430
language eng
recordid cdi_proquest_miscellaneous_1516756914
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Inhalation
Age Factors
Animals
Animals, Newborn
Biological and medical sciences
Blood Gas Analysis
Brain-Derived Neurotrophic Factor - metabolism
Cell Death
Cyclin-Dependent Kinase Inhibitor p27 - metabolism
Developing brain
Disease Models, Animal
Female
Hyperoxia
Hypoxia - complications
Leukoencephalopathies - etiology
Leukoencephalopathies - prevention & control
Lung - drug effects
Lung - physiopathology
Male
Medical sciences
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
Neuroprotection
Neuroprotective Agents - administration & dosage
Nitric oxide
Nitric Oxide - administration & dosage
Pregnancy
Rats
Rats, Sprague-Dawley
White matter damage
title Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T04%3A54%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhaled%20NO%20prevents%20hyperoxia-induced%20white%20matter%20damage%20in%20neonatal%20rats&rft.jtitle=Experimental%20neurology&rft.au=Pham,%20Hoa&rft.date=2014-02-01&rft.volume=252&rft.spage=114&rft.epage=123&rft.pages=114-123&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1016/j.expneurol.2013.11.025&rft_dat=%3Cproquest_cross%3E1516756914%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1491063045&rft_id=info:pmid/24322053&rft_els_id=S0014488613003580&rfr_iscdi=true